Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice.

NCT01893268 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01893268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01893268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
July 25, 2013
Completion date
March 20, 2018
Enrollment
279 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous non-small cell lung cancer